Related Experiment Video
Updated: Mar 27, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Temporal Disease Sequence and Prognostic Outcomes in Patients with Coexisting Lung Cancer and Tuberculosis: A
Wenfeng Yu1,2, Haoran Xie3, Bo Ye3
1Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
Background:
The concurrent presentation of pulmonary tuberculosis (TB) and lung cancer presents significant diagnostic and therapeutic challenges, with limited evidence guiding clinical management. To address this, we introduced a novel temporal disease-sequence classification. This study aimed to characterize clinical phenotypes and prognostic factors based on this sequence.
Methods:
We conducted a retrospective cohort study of 123 patients with confirmed TB and lung cancer at our center (2017-2023). Patients were classified by diagnostic sequence: Simultaneous Coexistence (TB-LC, n=70), Post-TB Lung Cancer (TB→LC, n=35), and Post-LC TB (LC→TB, n=18). Outcomes included demographics, symptom profiles, treatment patterns, and overall survival (OS). Statistical analyses employed Kaplan-Meier methods and Cox regression.
Results:
Striking intergroup differences were observed. The TB-LC group showed the highest symptom burden (87.14, P=0.007) and chemotherapy utilization (50.00%, P=0.029). OS did not differ significantly (log-rank P=0.276), though median survival varied (TB-LC: 32 months; LC→TB: 57 months; TB→LC: not reached). Multivariable analysis identified surgery (HR=0.34, 95% CI 0.13-0.92) and anti-TB therapy (HR=0.48, 95% CI 0.24-0.97) as protective factors, while advanced stage predicted mortality (HR=6.24, 95% CI 2.27-17.14).
Conclusion:
Temporal disease sequence influences clinical presentation and treatment selection in TB-lung cancer patients. Surgical resection and anti-TB strategies improve outcomes, highlighting the need for integrated management protocols.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders

